Shachi Engineering’s Post

PROFITABLE ACTIVE PHARMACEUTICAL INGREDIENT : LAMOTRIGINE You can Develop a Profitable & Sustainable Business by Manufacturing Lamotrigine and help the society fight against Central Nervous System Diseases. Let’ see Why…. WHY LAMOTRIGINE? Lamotrigine is a powerful Antiepileptic Molecule. It’s an Active Pharmaceutical Ingredient used in formulating Medicines to treat central nervous system diseases like of epileptic seizures and bipolar disorder. LAMOTRIGINE WORKS BY SLOWING DOWN THE ELECTRICAL SIGNALS DURING SEIZURES. HOW LAMOTRIGINE IS MANUFACTURED Lamotrigine is made by using multi-step Chemical Synthesis. ☑ When you make the molecule from the basic stage, you start with basic chemical feedstock. ☑ Using multi-step synthesis you make first Basic Pharmaceutical Intermediates and then Advanced Pharmaceutical Intermediates. ☑ Advanced Pharmaceutical Intermediates make the synthesis of Lamotrigine very easy. ☑ You need a multi-purpose Active Pharmaceutical Ingredient manufacturing facility designed for carrying out multi-step organic synthesis. ☑ The design and operation of the manufacturing facility must conform to good manufacturing practice suitable for making pharmaceutical products. MAKE THE MANUFACTURING COST-EFFICIENT ✔ Synthesize Lamotrigine from the Basic Stage using basic chemical feedstock. ✔ Optimize the Route of Synthesis of Lamotrigine. ✔ Improve the Yields to reduce the Manufacturing Costs. IN ORDER TO MAKE LAMOTRIGINE MANUFACTURING BUSINESS COST-EFFICIENT, YOU NEED TO IMPLEMENT PROCESS INDUSTRY INNOVATIONS EFFECTIVELY. However, Manufacturing Active Pharmaceutical Ingredients is knowledge-intensive and calls for a blend of technical and business expertise. Follow me for exclusive content. Connect with me for a personalized conversation and let’s discuss how my expertise can help you in solving industrial issues. I'm curious to hear your thoughts on this exciting topic. Share your insights in the comments below! Want to help in making the medicines affordable to all? Download our FREE ebook now and gain a competitive edge. It will not only introduce you to the High Potential Fast Growing Pharmaceutical Industry but also help you utilize the Incredible Opportunities it offers: https://lnkd.in/ddjA_byp #Lamotrigine #chemicalIndustry #pharmaceuticalIndustry #ActivePharmaceuticalIngredient #PharmaceuticalBusiness #ActivePharmaceuticalIngredientManufacturing #Epilepsy #AntiepilepticActivePharmaceuticalIngredients #CentralNervousSystemDisease #Entrepreneurship #Business #BusinessGrowth #TechnicalEntrepreneur

PROFITABLE ACTIVE PHARMACEUTICAL INGREDIENT : CARBAMAZEPINE You can Develop a Profitable & Sustainable Business by Manufacturing Carbamazepine and help the society fight against Central Nervous System Diseases. Let’ see Why…. WHY CARBAMAZEPINE? Carbamazepine is a powerful Antiepileptic Molecule. It’s an Active Pharmaceutical Ingredient used in formulating Medicines to treat central nervous system diseases like of epileptic seizures and bipolar disorder. CARBAMAZEPINE WORKS BY SUPPRESSING THE AABNORMAL BRAIN ELECTRICAL ACTIVITY. HOW CARBAMAZEPINE IS MANUFACTURED Carbamazepine is made by using multi-step Chemical Synthesis. ☑ When you make the molecule from the basic stage, you start with basic chemical feedstock. ☑ Using multi-step synthesis you make first Basic Pharmaceutical Intermediates and then Advanced Pharmaceutical Intermediates. ☑ Advanced Pharmaceutical Intermediates make the synthesis of Carbamazepine very easy. ☑ You need a multi-purpose Active Pharmaceutical Ingredient manufacturing facility designed for carrying out multi-step organic synthesis. ☑ The design and operation of the manufacturing facility must conform to good manufacturing practice suitable for making pharmaceutical products. MAKE THE MANUFACTURING COST-EFFICIENT ✔ Synthesize Carbamazepine from the Basic Stage using basic chemical feedstock. ✔ Optimize the Route of Synthesis of Carbamazepine. ✔ Improve the Yields to reduce the Manufacturing Costs. IN ORDER TO MAKE CARBAMAZEPINE MANUFACTURING BUSINESS COST-EFFICIENT, YOU NEED TO IMPLEMENT PROCESS INDUSTRY INNOVATIONS EFFECTIVELY. However, Manufacturing Active Pharmaceutical Ingredients is knowledge-intensive and calls for a blend of technical and business expertise. Follow me for exclusive content. Connect with me for a personalized conversation and let’s discuss how my expertise can help you in solving industrial issues. I'm curious to hear your thoughts on this exciting topic. Share your insights in the comments below! Want to help in making the medicines affordable to all? Download our FREE ebook now and gain a competitive edge. It will not only introduce you to the High Potential Fast Growing Pharmaceutical Industry but also help you utilize the Incredible Opportunities it offers: https://lnkd.in/ddjA_byp #Carbamazepine #chemicalIndustry #pharmaceuticalIndustry #ActivePharmaceuticalIngredient #PharmaceuticalBusiness #ActivePharmaceuticalIngredientManufacturing #Epilepsy #AntiepilepticActivePharmaceuticalIngredients #CentralNervousSystemDisease #Entrepreneurship #Business #BusinessGrowth #TechnicalEntrepreneur

PROFITABLE ACTIVE PHARMACEUTICAL INGREDIENT : AMLODIPINE You can Develop a Profitable & Sustainable Business by Manufacturing Amlodipine and help the society fight against Hypertension. Let’ see Why…. WHY AMLODIPINE? Amlodipine is a powerful Antihypertensive Molecule in the category of Calcium Channel Blocker. It’s an Active Pharmaceutical Ingredient used in formulating Medicines effective against Hypertension. AMLODIPINE WORK BY PREVENTING CALCIUM FROM ENTERING THE CELLS OF HEART AND ARTERIES. SO, THEY MAKE THE BLOOD VESSELS RELAXED AND OPEN UP. THIS RESULTS IN LOWERING DOWN THE BLOOD PRESSURE. HOW AMLODIPINE IS MANUFACTURED Amlodipine is made by using multi-step Chemical Synthesis. ☑ When you make the molecule from the basic stage, you start with basic chemical feedstock. ☑ Using multi-step synthesis you make first Basic Pharmaceutical Intermediates and then Advanced Pharmaceutical Intermediates. ☑ Advanced Pharmaceutical Intermediates make the synthesis of Amlodipine very easy. ☑ You need a multi-purpose Active Pharmaceutical Ingredient manufacturing facility designed for carrying out multi-step organic synthesis. ☑ The design and operation of the manufacturing facility must conform to good manufacturing practice suitable for making pharmaceutical products. MAKE THE MANUFACTURING COST-EFFICIENT ✔ Synthesize Amlodipine from the Basic Stage using basic chemical feedstock. ✔ Optimize the Route of Synthesis of Amlodipine. ✔ Improve the Yields to reduce the Manufacturing Costs. IN ORDER TO MAKE AMLODIPINE MANUFACTURING BUSINESS COST-EFFICIENT, YOU NEED TO IMPLEMENT PROCESS INDUSTRY INNOVATIONS EFFECTIVELY. However, Manufacturing Active Pharmaceutical Ingredients is knowledge-intensive and calls for a blend of technical and business expertise. Follow me for exclusive content. Connect with me for a personalized conversation and let’s discuss how my expertise can help you in solving industrial issues. I'm curious to hear your thoughts on this exciting topic. Share your insights in the comments below! Want to help in making the medicines affordable to all? Download our FREE ebook now and gain a competitive edge. It will not only introduce you to the High Potential Fast Growing Pharmaceutical Industry but also help you utilize the Incredible Opportunities it offers: https://lnkd.in/ddjA_byp #Amlodipine #chemicalIndustry #pharmaceuticalIndustry #ActivePharmaceuticalIngredient #PharmaceuticalBusiness #ActivePharmaceuticalIngredientManufacturing #AntihypertensiveActivePharmaceuticalIngredients #Hypertension #Entrepreneurship #Business #BusinessGrowth #TechnicalEntrepreneur

Pharmaceutical Excipients Market worth $13.9 billion Download a PDF Brochure: https://lnkd.in/ewsG-jDY "Pharmaceutical Excipients Market by Product (Organic (Oleochemicals, Carbohydrates) Inorganic (Calcium Carbonate), Functionality (Fillers, Binders, Lubricants, Diluents), Formulation (Oral, Parenteral), Application (Stablizers) - Global Forecast to 2028", is projected to reach USD 13.9 billion by 2028 from USD 10.0 billion in 2023, at a CAGR of 6.8% 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐬 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐅𝐥𝐚𝐯𝐨𝐫𝐬 & 𝐅𝐫𝐚𝐠𝐫𝐚𝐧𝐜𝐞𝐬 𝐈𝐧𝐜. (𝐔𝐒), 𝐀𝐬𝐡𝐥𝐚𝐧𝐝 𝐈𝐧𝐜. (𝐔𝐒), 𝐄𝐯𝐨𝐧𝐢𝐤 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐞𝐬 𝐀𝐆 (𝐆𝐞𝐫𝐦𝐚𝐧𝐲), 𝐁𝐀𝐒𝐅 𝐒𝐄 (𝐆𝐞𝐫𝐦𝐚𝐧𝐲), 𝐊𝐞𝐫𝐫𝐲 𝐆𝐫𝐨𝐮𝐩 𝐏𝐥𝐜 (𝐈𝐫𝐞𝐥𝐚𝐧𝐝), 𝐑𝐨𝐪𝐮𝐞𝐭𝐭𝐞 𝐅𝐫è𝐫𝐞𝐬 (𝐅𝐫𝐚𝐧𝐜𝐞), 𝐌𝐞𝐫𝐜𝐤 𝐊𝐠𝐚𝐀 (𝐆𝐞𝐫𝐦𝐚𝐧𝐲), 𝐀𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐞𝐝 𝐁𝐫𝐢𝐭𝐢𝐬𝐡 𝐅𝐨𝐨𝐝𝐬 𝐏𝐥𝐜 (𝐔𝐊), 𝐀𝐃𝐌 (𝐔𝐒), 𝐖𝐚𝐜𝐤𝐞𝐫 𝐂𝐡𝐞𝐦𝐢𝐞 𝐀𝐆 (𝐆𝐞𝐫𝐦𝐚𝐧𝐲). Other Companies that are Operating in this Market Globally: Otsuka Pharmaceutical Companies (U.S.) BioMarin Pharmaceutical Inc. Amoun Pharmaceutical Company Teva Active Pharmaceutical Ingredients  Par Pharmaceutical ROVI Pharmaceutical Company Novell Pharmaceutical Laboratories Emzor Pharmaceutical Industries Ltd Harte Hanks Unilab, Inc. Mallinckrodt Pharmaceuticals Lupin Pharmaceuticals  Eisai US Endo Omnicare, a CVS Health company Chiesi Group LEO Pharma Medley Biolab Sanus Farmacêutica Planet Pharma Twist Bioscience Kimberly-Clark Professional  Bruker SCIEX Eurofins Lancaster Laboratories Patheon Aspen Pharma Group IPS-Integrated Project Services Jabil Healthcare Almirall Abdi Ibrahim Pharmaceuticals ALKU The Jackson Laboratory Colorcon® PruittHealth   ConnectiveRx Sharp Services EVA pharma     Laboratório Teuto Virbac #PharmaExcipients #DrugFormulation #PharmaceuticalIngredients #TabletExcipients #ControlledRelease #FunctionalExcipients #OralDrugDelivery #PharmaceuticalFillers #BioavailabilityEnhancers #ExcipientInnovation

MANUFACTURE PROCESSES FOR ACTIVE PHARMACEUTICAL INGREDIENTS Know about the Manufacturing Processes to make your Pharmaceutical Business Profitable & Sustainable. Let’ see Why…. How to make medicines available at affordable prices? It’s possible when active pharmaceutical ingredients are manufactured efficiently. Because these active ingredients make the medicines effective. MANUFACTURING PROCESSES When you focus on the manufacturing processes you’ll find four different manufacturing processes. ✔ Chemical Synthesis ✔ Fermentation Process ✔ Enzymatic Reaction ✔ Extraction from Natural Sources CHEMICAL SYNTHESIS A major percentage of active pharmaceutical ingredient molecules are made by chemical synthesis. Once your products are synthesized they need to be separated and purified. Because the products are still in the reactor content along with many other molecules. So, you need suitable separation and purification processes. FERMENTATION TECHNOLOGY It’s not possible to make some active pharmaceutical ingredient molecules  by chemical synthesis. In those situations you can use Fermentation Technology. Specially developed microorganisms are allowed to grow in the reactors called Fermenters. But the product molecules are in the fermentation broth along with many other ingredients. So, you need powerful separation processes to isolate the molecules from the fermented broth. ENZYMATIC REACTIONS Enzymes are Biocatalysts. And the complex reactions become possible due to them. That’s why we utilize the power of enzymes for making some complex active pharmaceutical ingredients molecules. EXTRACTION FROM NATURAL SOURCES Natural sources contain many active pharmaceutical ingredients. These molecules are too complex. So it becomes economically efficient to get them from the natural sources. IN ORDER TO MAKE MEDICINES AVAILABLE TO ALL, YOU MUST SELECT THE RIGHT MANUFACTURING PROCESSES TO MAKE ACTIVE PHARMACEUTICAL INGREDIENTS. However, Manufacturing Active Pharmaceutical Ingredients is knowledge-intensive and calls for a blend of technical and business expertise. Follow me for exclusive content. Connect with me for a personalized conversation and let’s discuss how my expertise can help you in solving industrial issues. I'm curious to hear your thoughts on this exciting topic. Share your insights in the comments below! Want to make the medicines affordable to all? Download our FREE ebook now and gain a competitive edge. It will not only introduce you to the High Potential Fast Growing Pharmaceutical Industry but also help you utilize the Incredible Opportunities it offers: https://lnkd.in/ddjA_byp #chemicalIndustry #pharmaceuticalIndustry #ManufacturingProcess #ActivePharmaceuticalIngredient   #PharmaceuticalBusiness #ActivePharmaceuticalIngredientManufacturing #Entrepreneurship #Business #BusinessGrowth #TechnicalEntrepreneur

𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐄𝐱𝐜𝐢𝐩𝐢𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬: 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬, 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐮𝐭𝐮𝐫𝐞 𝐆𝐫𝐨𝐰𝐭𝐡 Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability. 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰: The global Pharmaceutical Excipients market was valued at US$ 98190 million in 2023 and is anticipated to reach US$ 143600 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030. 𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐄𝐱𝐜𝐢𝐩𝐢𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: DowDuPont, JRS PHARMA, BASF, The Lubrizol Corporation, Ashland, Croda, Roquette, Shin-Etsu, Evonik, Associated British Foods plc, sudzucker AG, Cosan Cinco S.A., Mitr Phol Group, Mitsubishi Corporation, Hunan Er-Kang Pharmaceutical Co., Ltd., anhui, Tianjin Chase Sun Pharmaceutical Co., Ltd. , Xiwang Group, SHENGTAI INTERNATIONAL GROUP LIMITED #PharmaceuticalExcipients #ExcipientsMarket #GlobalMarket #PharmaceuticalIndustry #MarketGrowth #PharmaExcipients #DrugFormulation #OralFormulations #Pharmaceuticals #IndustryTrends #MarketAnalysis #PharmaMarket #DrugManufacturing #ExcipientTechnology #MarketForecast #DowDuPont #JRSPharma #BASF #Lubrizol #Ashland #MarketReport #IndustryInsights #PharmaInnovation #HealthcareMarket #PharmaR&D #MarketSegmentation 𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐭𝐨 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐫𝐞𝐩𝐨𝐫𝐭, 𝐩𝐥𝐞𝐚𝐬𝐞 𝐯𝐢𝐬𝐢𝐭 : https://lnkd.in/dAbjZh7X

PROFITABLE ACTIVE PHARMACEUTICAL INGREDIENT : CILNIDIPINE You can Develop a Profitable & Sustainable Business by Manufacturing Cilnidipine and help the society fight against Hypertension. Let’ see Why…. WHY CILNIDIPINE? Cilnidipine is a powerful Antihypertensive Molecule in the category of Calcium Channel Blocker. It’s an Active Pharmaceutical Ingredient used in formulating Medicines effective against Hypertension. CILNIDIPINE WORK BY PREVENTING CALCIUM FROM ENTERING THE CELLS OF HEART AND ARTERIES. SO, THEY MAKE THE BLOOD VESSELS RELAXED AND OPEN UP. THIS RESULTS IN LOWERING DOWN THE BLOOD PRESSURE. HOW CILNIDIPINE IS MANUFACTURED Cilnidipine is made by using multi-step Chemical Synthesis. ☑ When you make the molecule from the basic stage, you start with basic chemical feedstock. ☑ Using multi-step synthesis you make first Basic Pharmaceutical Intermediates and then Advanced Pharmaceutical Intermediates. ☑ Advanced Pharmaceutical Intermediates make the synthesis of Cilnidipine very easy. ☑ You need a multi-purpose Active Pharmaceutical Ingredient manufacturing facility designed for carrying out multi-step organic synthesis. ☑ The design and operation of the manufacturing facility must conform to good manufacturing practice suitable for making pharmaceutical products. MAKE THE MANUFACTURING COST-EFFICIENT ✔ Synthesize Cilnidipine from the Basic Stage using basic chemical feedstock. ✔ Optimize the Route of Synthesis of Cilnidipine. ✔ Improve the Yields to reduce the Manufacturing Costs. IN ORDER TO MAKE CILNIDIPINE MANUFACTURING BUSINESS COST-EFFICIENT, YOU NEED TO IMPLEMENT PROCESS INDUSTRY INNOVATIONS EFFECTIVELY. However, Manufacturing Active Pharmaceutical Ingredients is knowledge-intensive and calls for a blend of technical and business expertise. Follow me for exclusive content. Connect with me for a personalized conversation and let’s discuss how my expertise can help you in solving industrial issues. I'm curious to hear your thoughts on this exciting topic. Share your insights in the comments below! Want to help in making the medicines affordable to all? Download our FREE ebook now and gain a competitive edge. It will not only introduce you to the High Potential Fast Growing Pharmaceutical Industry but also help you utilize the Incredible Opportunities it offers: https://lnkd.in/ddjA_byp #Cilnidipine #chemicalIndustry #pharmaceuticalIndustry #ActivePharmaceuticalIngredient #PharmaceuticalBusiness #ActivePharmaceuticalIngredientManufacturing #AntihypertensiveActivePharmaceuticalIngredients #Hypertension #Entrepreneurship #Business #BusinessGrowth #TechnicalEntrepreneur

processing to extraction pure crocin from the saffron field to its use in pharmaceutical, food and cosmetic products. #purr crocin #saffron extract #API

From $10B to $13.9B: Pharma Excipients Industry to Generate Revenue at 6.8% CAGR During Forecast Period Download PDF Brochure for Detailed Information@ https://lnkd.in/dHqytcur The global pharmaceutical excipients market in terms of revenue was estimated to be worth $10.0 billion in 2023 and is poised to reach $13.9 billion by 2028, growing at a CAGR of 6.8% from 2023 to 2028. The Companies Operating in This Market Globally: Ashland BASF Dow Roquette Evonik Colorcon® Croda Associated British Foods plc (ABF) ADM FMC Corporation JRS PHARMA DuPont de Nemours (Deutschland) GmbH WACKER Budenheim USA, Inc. SPI Pharma Signet Chemical Corporation Mallinckrodt Pharmaceuticals Pfanstiehl, Inc. MEGGLE Excipients DFE Pharma The Lubrizol Corporation Shin-Etsu Chemical Merck KGaA, Darmstadt, Germany Spectrum Chemical Mfg. Corp. Mitsubishi Chemical Group BENEO Daicel Chiral Technologies Süd-Chemie India Borregaard Jubilant Life Sciences (USA) Inc. SEPPIC Lonza Nouryon GATTEFOSSÉ

𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐄𝐱𝐜𝐢𝐩𝐢𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 size is forecast to reach US$ 21.1 billion by 2030, after growing at a CAGR of 7.50 % during the forecast period 2024-2035. 𝐆𝐞𝐭 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨 @ https://lnkd.in/giTUzCGY ◾ Generally, #Pharmaceutical Excipients refer to #substances other than active pharmaceutical ingredients (API) that have been precisely evaluated for safety, and are included intentionally for the purpose of #drug #delivery in a body.  ◾ #Cellulose esters are another pharmaceutical excipients that are widely used in #osmotic and enteric-coated #drug #delivery systems. Pharmaceutical Excipients can be further segmented into organic and inorganic #chemicals, and can be taken through the #oral, topical, or parenteral mode of administration. ◾ An increase in demand for #medical drugs, and #medicines along with increasing uptake of #biopharmaceuticals can act as major drivers for the market. Strict rules and regulations regarding the negative effects of the production of pharmaceutical excipients on the #environment can act as a major constraint for the market. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 👉 https://lnkd.in/gXhMiMEH 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Ashland DowDuPont BASF Evonik Kerry Roquette FMC Corporation The Lubrizol Corporation Croda ADM Colorcon® JRS PHARMA Avantor Merck Ingredion Incorporated Huntsman Corporation Eastman Asahi Kasei AkzoNobel Air Liquide